Netupitant/palonosetron (NEPA) and dexamethasone for prevention of emesis in breast cancer patients receiving adjuvant anthracycline plus cyclophosphamide: a multi-cycle, phase II studyRoberta Caputo, Michelino De Laurentiis, Monica Giordano et al.|BMC Cancer|2020Cited by 12
Efficacy of single administration of oral NEPA (netupitant plus palonosetron) and dexamethasone to prevent chemotherapy-induced nausea and vomiting (CINV) in breast cancer patients receiving adjuvant AC-based chemotherapy – Results from GIM15-NEPA StudyMichelino De Laurentiis, Sabino De Placido, Laura Amaducci et al.|European Journal of Cancer|2018Cited by 0
A multicenter phase II trial of nab‐paclitaxel and capecitabine in HER‐2 negative and triple‐ negative advanced breast cancer: Could be an old regimen a valid approach to a changing disease?Mariangela Ciccarese, Laura Orlando, Palma Fedele et al.|The Breast Journal|2020Cited by 0